Alimera Sciences Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Alimera Sciences prevailing Real Value cannot be determined due to lack of data. The current price of Alimera Sciences is $0.0. Our model approximates the value of Alimera Sciences from analyzing the firm fundamentals such as Profit Margin of (0.15) %, current valuation of 360.44 M, and Return On Equity of -0.35 as well as examining its technical indicators and probability of bankruptcy.
Alimera Sciences Total Value Analysis
Alimera Sciences is presently forecasted to have valuation of 360.44 M with market capitalization of 301.29 M, debt of 67.4 M, and cash on hands of 7.86 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Alimera Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
360.44 M | 301.29 M | 67.4 M | 7.86 M |
Alimera Sciences Investor Information
About 87.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 15th of November 2019. Alimera Sciences had 1:15 split on the 15th of November 2019. Based on the key indicators related to Alimera Sciences' liquidity, profitability, solvency, and operating efficiency, Alimera Sciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Alimera Sciences Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Alimera suggests not a very effective usage of assets in March.Alimera Sciences Ownership Allocation
Alimera Sciences holds a total of 54.38 Million outstanding shares. The majority of Alimera Sciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alimera Sciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alimera Sciences. Please pay attention to any change in the institutional holdings of Alimera Sciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Alimera Sciences Profitability Analysis
The company reported the previous year's revenue of 80.75 M. Net Loss for the year was (20.13 M) with profit before overhead, payroll, taxes, and interest of 52 M.Alimera Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Alimera Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25.6 M | |
| Forward Price Earnings | 26.3852 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |